News & Events
Use of metabolic syndrome drugs in multiple sclerosis
Drugs used for metabolic syndrome may reduce MS activity in people with MS and obesity
Bigger brains can protect against physical disability
Research suggests that higher brain growth is linked to lower risk for disability progression in people with…
Predicting long-term disability in MS
Australian researchers aim to predict future worsening of disability in people with relapse-onset MS
Canadian MS Society meets 75 MPs in 2 days
MS Society of Canada working hard to educate decision makers on MS
Simple adjustments could keep people with MS in work
Global MS Employment report highlights need for reasonable adjustments to help people with MS continue working.
EMSP Spring Conference: Growing with MS
Some of our team were lucky enough to attend the European MS Platform’s Spring Conference this month.
Could gut microbes play a role in MS?
Microbes in the body’s gastrointestinal system appear to change how myelin genes are expressed in the brain
A specialized eye test can predict disease progression in MS
Retinal thickness can be used as a measure to predict worsening disability in MS
Effectiveness of memory rehabilitation in people with MS
Review shows previous measures of memory rehabilitation were not reflective of daily life
Sex-specific differences in comorbid conditions in MS
Researchers find men with MS experience more chronic health problems at the time of diagnosis
Alternative to natalizumab in people at risk of a brain infection
Swedish study favours rituximab over fingolimod for those at risk of progressive multifocal leukoencephalopathy
Long term support for MSIF’s Du Pré Grants from the Netherlands
Stichting MS Research will fund two of MSIF’s Du Pré grants